The Daily Beast: Nasal Swab Test Predicts COVID Hospitalization Risk Using Flower Lose Protein

Published on October 20, 2021, this article from The Daily Beast discusses a significant discovery involving a nasal swab test that can predict COVID-19 hospitalization risk with high accuracy. The test identifies the presence of Flower Lose proteins (hFwe-Lose) in cells. Rajan Gogna, a cancer biologist, led the research, demonstrating that cells expressing these proteins are more susceptible to severe COVID-19 impacts. This discovery, predicted with 84-88% accuracy in studies, could revolutionize treatment planning for COVID-19 patients, particularly in hospital settings.

For a detailed read, you can visit the article on The Daily Beast.

Previous
Previous

IMPRS: Biomarker for Early Prediction of COVID-19 Severity Identified

Next
Next

BioTecNika: Cell Fitness Marker hFwe-Lose as a Predictor for Disease Outcomes